Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study

[1] D’Amico AV(1998)Biochemical outcome after radical prostatectomy, external beam radiotherapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1584-1586

[2] Whittington R(2000)Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation Int J Radiat Oncol Biol Phys 47 129-136

[3] Malkowicz SB(2004)Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seed/external beam radiotherapy for stage T1–T2 prostate cancer Int J Radiat Oncol Biol Phys 58 25-33

[4] Shultz D(2007)Quality of life after surgery, external beam irradiation, or brachytherapy for early stage prostate cancer Cancer 109 2239-2247

[5] Blank K(2007)An assement of quality of life following radical prostatectomy, high-dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer J Urol 177 2151-2156

[6] Broderick GA(2004)Permanent I-125 seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results BJU Int 94 805-811

[7] Tomaszewski JE(2007)Erectile function outcome reporting after clinically localized prostate cancer treatment J Urol 178 597-601

[8] Renshaw AA(2007)Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2106-2131

[9] Kaplan I(1999)American Brachytherapy Society reccomendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 789-799

[10] Beard CJ(1992)The American Urological Association symptom index for benign prostatic hyperplasia J Urol 148 1549-1556

[1] D’Amico AV(1998)Biochemical outcome after radical prostatectomy, external beam radiotherapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1584-1586

[2] Whittington R(2000)Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation Int J Radiat Oncol Biol Phys 47 129-136

[3] Malkowicz SB(2004)Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seed/external beam radiotherapy for stage T1–T2 prostate cancer Int J Radiat Oncol Biol Phys 58 25-33

[4] Shultz D(2007)Quality of life after surgery, external beam irradiation, or brachytherapy for early stage prostate cancer Cancer 109 2239-2247

[5] Blank K(2007)An assement of quality of life following radical prostatectomy, high-dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer J Urol 177 2151-2156

[6] Broderick GA(2004)Permanent I-125 seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results BJU Int 94 805-811

[7] Tomaszewski JE(2007)Erectile function outcome reporting after clinically localized prostate cancer treatment J Urol 178 597-601

[8] Renshaw AA(2007)Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2106-2131

[9] Kaplan I(1999)American Brachytherapy Society reccomendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 789-799

[10] Beard CJ(1992)The American Urological Association symptom index for benign prostatic hyperplasia J Urol 148 1549-1556